MicroEpitope: an atlas of immune epitopes derived from cancer microbiomes
Nucleic Acids Research · 06.01.2025 · 53 (D1) · D1435-D1442
DOI: 10.1093/nar/gkae877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 09.10.2024. Verfasst von Donghao Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province 150081, China. Hauptthemen laut MEDLINE: Neoplasms, Microbiota. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
The majority of human cancers harbor molecular evidence of intratumoral microbiota. Microbiota-derived epitopes as molecular mimics of tumor antigens can bind human leukocyte antigen (HLA), thereby modulating host immunity. However, many questions remain regarding the mechanisms underlying the interactions between microbiota and the host's immune system in cancer. Here, MicroEpitope (http://bio-bigdata.hrbmu.edu.cn/MicroEpitope) was developed to provide and analyze the atlas of microbiota-derived epitopes in cancer. We manually collected available mass spectrometry (MS)-based HLA immunopeptidomes of 1190 samples across 24 cancer types. Alignment was performed against an in-house constructed theoretical library of human and intratumor microbiome encoded proteins, including 1298 bacterial and 124 viral species. Currently, MicroEpitope contains 51 497 bacteria and 767 virus-derived epitopes, mainly originating from Bacillus subtilis, Buchnera aphidicola and human cytomegalovirus. The common immunogenic features of epitopes were calculated, as well as their biochemical properties and the clinical relevance of corresponding bacteria and viruses across cancers. MicroEpitope also provides five analytical tools, and multiple visualization methods to facilitate understanding of the roles of microbiota-derived epitopes in cancer immunity. In summary, MicroEpitope represents a vital resource for investigating HLA-presented immunopeptidomes derived from cancer microbiomes, and could further enable rich insight in tumor antigen prioritization strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province 150081, China.
- School of Interdisciplinary Medicine and Engineering, Harbin Medical University, Harbin, Heilongjiang Province 150081, China.
ORCID-Profile: Yongsheng Li, Juan Xu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Li, D., Cai, Y., Liu, K., Lv, D., Zeng, M., Wen, L., Lv, C., Guo, J., Xu, K., Ding, N., Li, Y., & Xu, J. (2025). MicroEpitope: an atlas of immune epitopes derived from cancer microbiomes. Nucleic Acids Research, 53(D1), D1435-D1442. https://doi.org/10.1093/nar/gkae877
Vancouver
Li D, Cai Y, Liu K, Lv D, Zeng M, Wen L, et al. MicroEpitope: an atlas of immune epitopes derived from cancer microbiomes. Nucleic Acids Research. 2025;53(D1):D1435-D1442. doi:10.1093/nar/gkae877
BibTeX
@article{Li2025,
author = {Li, Donghao and Cai, Yangyang and Liu, Kefan and Lv, Dezhong and Zeng, Mengqian and Wen, Luan and Lv, Chongwen and Guo, Jiyu and Xu, Kang and Ding, Na and Li, Yongsheng and Xu, Juan},
title = {MicroEpitope: an atlas of immune epitopes derived from cancer microbiomes},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {D1},
pages = {D1435--D1442},
doi = {10.1093/nar/gkae877}
}
EUVIMED